MIR1972-2

Across TCGA pan-cancer cohorts, MIR1972-2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR1972-2 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher MIR1972-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR1972-2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

PAAD, THCA, and KICH are the cancer types where MIR1972-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	II,III,IV	0.273	0.482	.003	63	view →
THCA	OS	Tertile	II,III,IV	0.429	0.865	<.001	51	view →
KICH	OS	Tertile	III,IV	0.190	0.803	.007	48	view →
LUAD	DFS	Tertile	All	0.912	0.720	.001	39	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	24	view →
BLCA	OS	Tertile	III,IV	0.800	0.657	.028	15	view →
PCPG	OS	Tertile	All	0.916	1.000	.010	15	view →
ACC	OS	Tertile	All	0.549	0.846	.020	9	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
STAD	OS	Tertile	All	0.626	0.466	.030	6	view →
ESCA	OS	Tertile	IV	0.373	0.916	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR1972-2–PAAD (OS)

Open the PAAD breakdown →